Illumina, Blue Cross Blue Shield Association Partner on Precision Medicine Report

Illumina and the Blue Cross Blue Shield Association will partner in order to develop a better understanding of the state of precision medicine in the US.

The companies said they plan to write a report on the utilization of precision medicine by early 2019 that details the availability and clinical understanding of DNA sequencing technologies, genetic testing, and precision medicine.

Source: https://www.genomeweb.com/sequencing/illumina-blue-cross-blue-shield-association-partner-precision-medicine-report